Go to deals
Other Industries

Argonaut Resources (ASX:ARE) has completed a fundraising

Argonaut Resources NL (ASX:ARE) has raised US$3.6 million via a placement. The funds will be used to accelerate a drilling and scoping study program at Lumwana West in Zambia and drilling at Murdie in South Australia, providing working capital and covering transaction costs. The placement to professional and sophisticated investors received strong support and was well oversubscribed.

Argonaut Resources holds exciting assets in prominent prospecting areas, with exposure to copper, cobalt, gold and uranium. With buoyant demand and commodity prices in its target mineral portfolio, particularly including copper, the company foresees good potential upside. Key assets include the 90%-owned Lumwana West copper–cobalt project in north-western Zambia and 100%-owned Murdie iron oxide copper gold (IOCG) targets in South Australia.

Oaklins’ team in Australia acted as lead manager in this transaction.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Paul  Young

Paul Young

Senior Advisor

Sydney, Australia
Oaklins Henslow
 Peter  Fraser

Peter Fraser

Director

Sydney, Australia
Oaklins Henslow

Related deals

Alice Queen (ASX:AQX) has raised funds via an institutional placement
Other Industries

Alice Queen (ASX:AQX) has raised funds via an institutional placement

Alice Queen Limited (ASX:AQX) has completed a fundraising. The funds will be used to complete the Horn Island Scoping Study, accelerate exploration activities at Horn Island and support working capital. The placement was significantly oversubscribed and strongly supported by a major shareholder, as well as several existing shareholders and new institutional and sophisticated investors.

Learn more
Bigtincan (ASX:BTH) has raised capital to fund the acquisition of Brainshark Inc.
TMT

Bigtincan (ASX:BTH) has raised capital to fund the acquisition of Brainshark Inc.

Bigtincan Holdings Limited (ASX:BTH) has raised US$98.6 via a placement and underwritten accelerated non-renounceable entitlement offer.

Learn more
Poolbeg Pharma has completed an Initial Public Offering on AIM
Healthcare

Poolbeg Pharma has completed an Initial Public Offering on AIM

Poolbeg Pharma Plc has raised funds to develop the company.

Learn more